Related Experiment Video
Updated: Oct 11, 2026

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
Fluid responsiveness-guided preinduction volume optimization and postinduction hypotension in older adults at
Miao Wang1, Cheng Xu1, Chunyang Zhang1
1Department of Anesthesiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Shanghai 200233, China.
Study Objective:
To determine whether preinduction volume optimization guided by fluid responsiveness reduces postinduction hypotension in older adults at increased frailty risk.
Design:
Single-center randomized controlled trial.
Setting:
Shanghai Sixth People's Hospital, Shanghai, China.
Patients:
One hundred adults aged 65 years or older with Risk Analysis Index-C scores greater than 15 undergoing elective gastrointestinal surgery.
Interventions:
Participants were assigned 1:1 to preinduction volume optimization guided by passive leg raising and echocardiographic left ventricular outflow tract velocity-time integral, or usual care. Fluid-responsive participants received 8 mL/kg succinylated gelatin boluses until optimization.
Measurements:
The primary outcome was the occurrence of any mean arterial pressure (MAP) below 65 mmHg during postinduction minutes 1 through 15.
Main Results:
Forty-six of 50 optimization participants were fluid responsive and received colloid. At least 1 MAP value below 65 mmHg occurred in 19 of 50 participants (38%) with optimization and 36 of 50 (72%) with usual care (risk difference, -34.0 percentage points [95% CI, -50.1 to -14.5]; relative risk, 0.53 [95% CI, 0.36 to 0.78]; P = .001). The number needed to treat was 3 (95% CI, 2 to 7), and the fragility index was 7. The mean minimum MAP differed by 4.3 mmHg; the median number of scheduled observations below 65 mmHg was 0 vs 2.
Conclusions:
In selected older adults at increased frailty risk, preinduction volume optimization reduced early postinduction hypotension. Differences in hypotension depth and burden were modest, and clinical benefit remains uncertain.
Clinical Trial Registration:
Chinese Clinical Trial Registry (ChiCTR2500095294; registered 6 January 2025; https://www.chictr.org.cn/showproj.html?proj=255888).
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Heart Failure V: Medical Management
Mitral Regurgitation IV: Nursing Management